Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab.

@article{Pastore2011GlutathionePA,
  title={Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab.},
  author={Saveria Pastore and Valentina Mariani and Daniela Lulli and Emanuela Gubinelli and Desanka Raskovic and Serena Mariani and Andrea Stancato and Chiara de Luca and Alessandra Pecorelli and Giuseppe Valacchi and Alla I. Potapovich and Vladimir A. Kostyuk and Liudmila Korkina},
  journal={Free radical research},
  year={2011},
  volume={45 5},
  pages={585-99}
}
Biological treatment of psoriasis, a chronic inflammatory immune-mediated pathology of huge social impact, has become a recent revolutionizing breakthrough in the management of the disease. Apart from anti-TNF-alpha biologics, recombinant proteins-inhibitors of the T lymphocytes-antigen presenting cells interaction, Efalizumab among them, have been… CONTINUE READING